Wallington Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3M Sell
195,338
-631
-0.3% -$50.9K 1.88% 23
2026
Q1
$17M Sell
195,969
-5,304
-3% -$508K 2.26% 21
2025
Q4
$19.3M Buy
201,273
+230
+0.1% +$22.3K 2.45% 14
2025
Q3
$19.1M Buy
201,043
+1,097
+0.5% +$101K 2.48% 14
2025
Q2
$17.4M Buy
199,946
+3,094
+2% +$262K 2.45% 14
2025
Q1
$17.7M Buy
196,852
+2,310
+1% +$207K 2.55% 13
2024
Q4
$15.5M Buy
194,542
+1,413
+0.7% +$122K 2.25% 15
2024
Q3
$17.4M Buy
193,129
+9,694
+5% +$815K 2.42% 14
2024
Q2
$14.4M Buy
183,435
+597
+0.3% +$48.9K 2.21% 16
2024
Q1
$15.9M Buy
182,838
+3,615
+2% +$309K 2.5% 14
2023
Q4
$14.8M Buy
179,223
+929
+0.5% +$70.8K 2.49% 13
2023
Q3
$14M Buy
178,294
+733
+0.4% +$61.4K 2.54% 13
2023
Q2
$15.6M Buy
177,561
+2,808
+2% +$242K 2.81% 11
2023
Q1
$14.1M Buy
174,753
+1,590
+0.9% +$130K 2.82% 13
2022
Q4
$13.5M Sell
173,163
-534
-0.3% -$43.3K 2.91% 13
2022
Q3
$14M Buy
173,697
+302
+0.2% +$27.1K 3.32% 10
2022
Q2
$15.6M Buy
173,395
+1,116
+0.6% +$113K 3.16% 11
2022
Q1
$19.1M Buy
172,279
+2,077
+1% +$219K 3.31% 7
2021
Q4
$17.6M Sell
170,202
-1,790
-1% -$207K 2.69% 13
2021
Q3
$21.6M Buy
171,992
+697
+0.4% +$90.2K 3.59% 4
2021
Q2
$21.3M Buy
171,295
+3,815
+2% +$479K 3.65% 4
2021
Q1
$19.8M Sell
167,480
-1,793
-1% -$210K 3.58% 4
2020
Q4
$19.8M Buy
169,273
+2,061
+1% +$227K 3.87% 7
2020
Q3
$17.4M Buy
167,212
+2,640
+2% +$265K 4.02% 6
2020
Q2
$15.1M Buy
164,572
+290
+0.2% +$27.8K 3.74% 8
2020
Q1
$14.8M Buy
164,282
+360
+0.2% +$38.3K 4.1% 5
2019
Q4
$18.6M Buy
163,922
+3,880
+2% +$426K 3.95% 3
2019
Q3
$17.4M Buy
160,042
+6,310
+4% +$658K 4.21% 4
2019
Q2
$15M Buy
153,732
+3,570
+2% +$326K 3.7% 6
2019
Q1
$13.7M Buy
150,162
+2,704
+2% +$242K 3.57% 9
2018
Q4
$13.4M Buy
147,458
+422
+0.3% +$39.4K 4.01% 6
2018
Q3
$14.5M Buy
147,036
+4,118
+3% +$381K 3.46% 7
2018
Q2
$12.2M Buy
142,918
+4,694
+3% +$392K 3.13% 10
2018
Q1
$11.1M Buy
138,224
+401
+0.3% +$33.1K 2.94% 13
2017
Q4
$11.1M Buy
137,823
+533
+0.4% +$42.7K 2.86% 13
2017
Q3
$10.7M Buy
137,290
+2,239
+2% +$186K 2.83% 11
2017
Q2
$12M Buy
135,051
+2,043
+2% +$172K 3.33% 6
2017
Q1
$10.7M Buy
133,008
+3,010
+2% +$235K 3.05% 7
2016
Q4
$9.26M Sell
129,998
-696
-0.5% -$54.7K 2.87% 11
2016
Q3
$11.3M Buy
130,694
+912
+0.7% +$79.5K 3.71% 5
2016
Q2
$11.3M Buy
129,782
+5,417
+4% +$438K 3.51% 7
2016
Q1
$9.33M Buy
124,365
+6,952
+6% +$524K 3.05% 9
2015
Q4
$9.03M Buy
117,413
+1,965
+2% +$148K 3.11% 9
2015
Q3
$7.73M Buy
115,448
+2,800
+2% +$206K 2.78% 13
2015
Q2
$8.35M Buy
112,648
+2,619
+2% +$200K 2.67% 12
2015
Q1
$8.58M Buy
110,029
+9,890
+10% +$750K 2.68% 13
2014
Q4
$7.23M Buy
100,139
+470
+0.5% +$32.6K 2.31% 20
2014
Q3
$6.17M Buy
99,669
+353
+0.4% +$22.4K 2.09% 23
2014
Q2
$6.33M Buy
99,316
+3,020
+3% +$183K 2.16% 23
2014
Q1
$5.93M Buy
96,296
+2,973
+3% +$173K 2.08% 22
2013
Q4
$5.36M Buy
93,323
+5,610
+6% +$318K 1.96% 26
2013
Q3
$4.67M Buy
87,713
+970
+1% +$52.2K 1.92% 26
2013
Q2
$4.46M Buy
+86,743
New +$4.29M 1.9% 27

Other funds holding MDT

Wallington Asset Management's MDT Position: Q2 2026 in Review

Wallington Asset Management reduced its Medtronic (MDT) stake by 0.32% in Q2 2026, selling an estimated $50.9K and leaving 195,338 shares worth $15.3M. The position accounts for 1.88% of the portfolio, ranked #23.

Wallington Asset Management first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.6M in Q3 2021. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Wallington Asset Management held 195,338 shares of Medtronic worth $15.3M as of Q2 2026.
  • Wallington Asset Management sold 631 Medtronic shares in Q2 2026, an estimated $50.9K.
  • Medtronic made up 1.88% of Wallington Asset Management's portfolio in Q2 2026, its #23 holding.
  • Wallington Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Wallington Asset Management's Medtronic position peaked at $21.6M in Q3 2021.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Wallington Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.